• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型免疫将免疫检查点抑制剂引起的湿疹样和苔藓样皮疹联系起来。

Type 2 immunity links eczematous and lichenoid eruptions caused by immune checkpoint inhibitors.

作者信息

Azin Marjan, Farokh Parisa, McGarry Alexander, Leung Bonnie W, Roster Kathleen, Rashdan Hannah, Rajeh Ahmad, Khattab Sara, Stephens Michael R, Thang Christopher Jayee, Fisher David E, Nazarian Rosalynn M, Chen Steven T, Semenov Yevgeniy R, Demehri Shadmehr

机构信息

Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

出版信息

J Am Acad Dermatol. 2025 Aug 8. doi: 10.1016/j.jaad.2025.08.008.

DOI:10.1016/j.jaad.2025.08.008
PMID:40784562
Abstract

BACKGROUND

Cutaneous immune-related adverse events (cirAEs) induced by immune checkpoint inhibitor (ICI) therapy share clinical features with spontaneous inflammatory dermatoses. However, the exact immunopathogenesis of cirAEs remains unclear.

OBJECTIVE

To investigate the inflammation that mediates the most common cirAEs, lichenoid eruption (LE) and eczematous eruption (EE).

METHODS

In a prospective cohort study, participants with cancer on ICI therapy with any clinically visible cirAEs were enrolled. T helper-1 (Th1) and Th2 cell responses in cirAEs were compared to spontaneous lichenoid dermatitis and eczematous dermatitis.

RESULTS

Among 88 cirAE biopsies collected, LE (35.22%) and EE (31.81%) accounted for most cases. In contrast to lichenoid dermatitis, we found that the CD4/CD8 T-cells and Th2/Th1 ratios were increased in ICI-induced LE, similar to EE. Importantly, we identified several cirAEs displaying a combination of LE and EE on pathology.

LIMITATIONS

Only the most common types of cirAEs were evaluated, and Th17 cells were not analyzed.

CONCLUSION

Our findings indicate that LE and EE may represent a cirAE spectrum with a common underlying immunologic mechanism. Thus, understanding the immunopathogenesis of cirAEs can aid in their treatment and prevention.

摘要

背景

免疫检查点抑制剂(ICI)治疗引起的皮肤免疫相关不良事件(cirAEs)与自发性炎症性皮肤病具有共同的临床特征。然而,cirAEs的确切免疫发病机制仍不清楚。

目的

研究介导最常见的cirAEs,即苔藓样疹(LE)和湿疹样疹(EE)的炎症。

方法

在一项前瞻性队列研究中,纳入接受ICI治疗且出现任何临床可见cirAEs的癌症患者。将cirAEs中的辅助性T细胞1(Th1)和Th2细胞反应与自发性苔藓样皮炎和湿疹样皮炎进行比较。

结果

在收集的88份cirAE活检样本中,LE(35.22%)和EE(31.81%)占大多数病例。与苔藓样皮炎不同,我们发现ICI诱导的LE中CD4/CD8 T细胞和Th2/Th1比值升高,与EE相似。重要的是,我们在病理学上发现了几种同时表现为LE和EE的cirAEs。

局限性

仅评估了最常见类型的cirAEs,未分析Th17细胞。

结论

我们的研究结果表明,LE和EE可能代表具有共同潜在免疫机制的cirAE谱。因此,了解cirAEs的免疫发病机制有助于其治疗和预防。

相似文献

1
Type 2 immunity links eczematous and lichenoid eruptions caused by immune checkpoint inhibitors.2型免疫将免疫检查点抑制剂引起的湿疹样和苔藓样皮疹联系起来。
J Am Acad Dermatol. 2025 Aug 8. doi: 10.1016/j.jaad.2025.08.008.
2
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study.癌症类型和组织学影响皮肤免疫治疗的毒性:一项多机构队列研究。
Br J Dermatol. 2024 Jun 20;191(1):117-124. doi: 10.1093/bjd/ljae053.
3
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.抗程序性细胞死亡蛋白 1 和抗程序性细胞死亡配体 1 治疗的患者中皮肤免疫相关不良事件与生存改善相关。
JAMA Dermatol. 2022 Feb 1;158(2):189-193. doi: 10.1001/jamadermatol.2021.5476.
4
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment: A Systematic Review and Meta-Analysis.免疫检查点抑制剂治疗的皮肤不良反应与癌症生存预后:系统评价和荟萃分析。
JAMA Dermatol. 2023 Oct 1;159(10):1093-1101. doi: 10.1001/jamadermatol.2023.3003.
5
Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors.免疫检查点抑制剂诱导的皮肤免疫相关不良事件的组织学和免疫特征
J Immunother Cancer. 2025 Aug 7;13(8):e011401. doi: 10.1136/jitc-2024-011401.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy.子宫内膜癌中的免疫格局与肿瘤相关巨噬细胞密度:对免疫检查点抑制剂疗效的影响
Ther Adv Med Oncol. 2025 Aug 8;17:17588359251347364. doi: 10.1177/17588359251347364. eCollection 2025.
9
Incidence Rates of Cutaneous Immune-Related Adverse Events in Patients with Lung Cancer: A Systematic Review and Meta-Analysis.肺癌患者皮肤免疫相关不良事件的发生率:一项系统评价和荟萃分析
Curr Oncol. 2025 Mar 27;32(4):195. doi: 10.3390/curroncol32040195.
10
Antihypertensive Medications and Eczematous Dermatitis in Older Adults.抗高血压药物与老年人湿疹性皮炎。
JAMA Dermatol. 2024 Jul 1;160(7):710-716. doi: 10.1001/jamadermatol.2024.1230.